PT2349243E - Soluções formadoras de película a base de ureia para o tratamento de psoríase ungueal - Google Patents

Soluções formadoras de película a base de ureia para o tratamento de psoríase ungueal Download PDF

Info

Publication number
PT2349243E
PT2349243E PT97599120T PT09759912T PT2349243E PT 2349243 E PT2349243 E PT 2349243E PT 97599120 T PT97599120 T PT 97599120T PT 09759912 T PT09759912 T PT 09759912T PT 2349243 E PT2349243 E PT 2349243E
Authority
PT
Portugal
Prior art keywords
ungueal
ureia
psoriasis
treatment
based film
Prior art date
Application number
PT97599120T
Other languages
English (en)
Portuguese (pt)
Inventor
Delaunois Marlène
Chesnoy Sophie
Coubetergues Héla
Lefrancois Pascal
Original Assignee
Pierre Fabre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique filed Critical Pierre Fabre Dermo Cosmetique
Publication of PT2349243E publication Critical patent/PT2349243E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT97599120T 2008-10-21 2009-10-21 Soluções formadoras de película a base de ureia para o tratamento de psoríase ungueal PT2349243E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0857146A FR2937250B1 (fr) 2008-10-21 2008-10-21 Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle

Publications (1)

Publication Number Publication Date
PT2349243E true PT2349243E (pt) 2016-03-14

Family

ID=40823172

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97599120T PT2349243E (pt) 2008-10-21 2009-10-21 Soluções formadoras de película a base de ureia para o tratamento de psoríase ungueal

Country Status (23)

Country Link
US (1) US20110200544A1 (enExample)
EP (1) EP2349243B1 (enExample)
JP (1) JP2012506372A (enExample)
KR (1) KR20110071118A (enExample)
CN (1) CN102186468B (enExample)
AR (1) AR074048A1 (enExample)
AU (1) AU2009306462B2 (enExample)
BR (1) BRPI0919833A2 (enExample)
CA (1) CA2740001A1 (enExample)
ES (1) ES2560178T3 (enExample)
FR (1) FR2937250B1 (enExample)
GE (1) GEP20135746B (enExample)
IL (1) IL212372A0 (enExample)
MA (1) MA32800B1 (enExample)
MX (1) MX2011004016A (enExample)
NZ (1) NZ592733A (enExample)
PL (1) PL2349243T3 (enExample)
PT (1) PT2349243E (enExample)
RU (1) RU2508090C2 (enExample)
TN (1) TN2011000167A1 (enExample)
UA (1) UA102705C2 (enExample)
WO (1) WO2010046375A1 (enExample)
ZA (1) ZA201103437B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
CN104758273B (zh) * 2015-04-09 2018-04-20 山东罗欣药业集团股份有限公司 一种尿素微囊制剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
DE10061801A1 (de) * 2000-01-03 2001-07-12 Karl Kraemer Zubereitungen zur atraumatischen Nagelentfernung
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
WO2002055023A2 (en) * 2001-01-09 2002-07-18 Israel Dvoretzky Therapeutic film forming composition and treatment system
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6821508B2 (en) * 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
BR0212290A (pt) * 2001-09-04 2004-09-14 Trommsdorff Arzneimittel Emplastro para o tratamento de disfunções e distúrbios de unhas
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
JP2005538156A (ja) * 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
WO2005011565A2 (fr) * 2003-07-29 2005-02-10 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff

Also Published As

Publication number Publication date
IL212372A0 (en) 2011-06-30
AU2009306462A1 (en) 2010-04-29
PL2349243T3 (pl) 2016-07-29
ES2560178T3 (es) 2016-02-17
NZ592733A (en) 2012-03-30
CN102186468B (zh) 2014-02-12
RU2508090C2 (ru) 2014-02-27
RU2011119924A (ru) 2012-11-27
HK1156532A1 (en) 2012-06-15
US20110200544A1 (en) 2011-08-18
FR2937250B1 (fr) 2013-05-10
GEP20135746B (en) 2013-02-11
BRPI0919833A2 (pt) 2015-12-15
TN2011000167A1 (en) 2012-12-17
EP2349243B1 (en) 2015-11-11
KR20110071118A (ko) 2011-06-28
JP2012506372A (ja) 2012-03-15
CA2740001A1 (en) 2010-04-29
FR2937250A1 (fr) 2010-04-23
MX2011004016A (es) 2011-05-19
EP2349243A1 (en) 2011-08-03
AU2009306462B2 (en) 2013-08-22
WO2010046375A1 (en) 2010-04-29
MA32800B1 (fr) 2011-11-01
UA102705C2 (ru) 2013-08-12
CN102186468A (zh) 2011-09-14
ZA201103437B (en) 2012-01-25
AR074048A1 (es) 2010-12-22

Similar Documents

Publication Publication Date Title
BRPI0917675A2 (pt) compostos orgânicos para cura de ferida
BRPI0915879A2 (pt) dispositivos médicos temporariamente posicionáveis
EP2191435A4 (en) MONITORING HEALTH CARE
DK2195058T3 (da) Laryngealmaske
EP2255962A4 (en) FILM WITH HIGH RESISTANCE
BRPI0910282A2 (pt) Composto oxadiazo-antraceno para o tratamento de diabetes
EP2133387A4 (en) POROUS FILM
HRP20181851T1 (hr) Višeslojna folija
DK2382009T3 (da) Bestrålingsindretning
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0908715A2 (pt) métodos para tratamento da psoríase
EP2253466A4 (en) Mold release film
EP2347741A4 (en) FILM ASSOCIATION
EP2289996A4 (en) FLUOR RESIN FILM
DE112008003934A5 (de) Kosmetikmaske
DK2271618T3 (da) Farmaceutiske forbindelser
FI20080181L (fi) Laippakäämitys
EP2251719A4 (en) PEEL FILM
PL2387493T3 (pl) Zastosowanie folii etykietowej do procesów głębokiego tłoczenia
BRPI0913872A2 (pt) multi-bandagem
PT2349243E (pt) Soluções formadoras de película a base de ureia para o tratamento de psoríase ungueal
BRPI0909764A2 (pt) compostos terapêuticos
FI8431U1 (fi) Kaavinlaite
DE112008000259A5 (de) Aufspuleinrichtung